Filing Flows › Shoulder Innovations (SI) › Recalls, complaints & regulation
Shoulder Innovations (SI): clinical trials
Shoulder Innovations (SI) beyond its filings: 1 active clinical trial.
Shoulder Innovations' latest quarter
Shoulder Innovations, Q3 2026: revenue $16.2M (+38% year over year), operating margin -46.9%, net loss $7.0M, operating cash flow −$6.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Shoulder Innovations have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.